Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2021-03-15 Sale | 2021-03-16 5:11 pm | Flexion Therapeutics Inc | FLXN | Layman Melissa Chief Commercial Officer | 4,520 | $11.8 | $53,336 | 103,956 (Direct) | View |
2021-01-28 Sale | 2021-01-29 8:19 pm | Flexion Therapeutics Inc | FLXN | Layman Melissa Chief Commercial Officer | 2,624 | $12.55 | $32,931 | 88,376 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2021-11-19 Disposition | 2021-11-19 10:03 am | N/A 2030-03-31 | Flexion Therapeutics Inc | FLXN | Layman Melissa Chief Commercial Officer | 50,100 | $0 | 0 (Direct) | View |
2021-11-19 Disposition | 2021-11-19 10:03 am | N/A N/A | Flexion Therapeutics Inc | FLXN | Layman Melissa Chief Commercial Officer | 103,956 | $8.5 | 0 (Direct) | View |
2021-03-01 Option Award | 2021-03-03 6:22 pm | N/A N/A | Flexion Therapeutics Inc | FLXN | Layman Melissa Chief Commercial Officer | 50,250 | $0 | 138,626 (Direct) | View |
2021-01-27 Option Award | 2021-01-29 8:19 pm | N/A N/A | Flexion Therapeutics Inc | FLXN | Layman Melissa Chief Commercial Officer | 30,000 | $0 | 88,376 (Direct) | View |
2020-04-01 Option Award | 2020-04-03 4:11 pm | N/A 2030-03-31 | Flexion Therapeutics Inc | FLXN | Layman Melissa Chief Commercial Officer | 121,000 | $0 | 121,000 (Direct) | View |